Gastric outlet obstruction: Difference between revisions
No edit summary |
No edit summary |
||
| Line 138: | Line 138: | ||
Bleeding | Bleeding | ||
Perforation | Perforation | ||
| Line 313: | Line 312: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
Benign Gastric Outlet Obstruction due to Peptic Ulcer Disease (PUD): | |||
Medical therapy is given in patients in case of: | |||
Acute inflammation | |||
Edema | Edema | ||
Prior to surgery: | |||
Gastric decompression | |||
Hydration | |||
Treatment of electrolyte imbalances | Treatment of electrolyte imbalances | ||
Palliative therapy for cases of advanced cancer: | |||
Endoscopic stent placement | Endoscopic stent placement | ||
Medical Therapy | Medical Therapy | ||
Hydration | Hydration | ||
Correction of electrolyte imbalances | Correction of electrolyte imbalances | ||
NaCl solution to correct hypochloremia | NaCl solution to correct hypochloremia | ||
Replacement of potassium | Replacement of potassium | ||
Repletion of volume status | Repletion of volume status | ||
Placement of a nasogastric (NG) tube for stomach decompression | Placement of a nasogastric (NG) tube for stomach decompression | ||
Jejunostomy tube may be placed during surgery | Jejunostomy tube may be placed during surgery | ||
In case of PUD: | In case of PUD: | ||
Histamine-2 (H2) blockers | Histamine-2 (H2) blockers | ||
Proton pump inhibitors | Proton pump inhibitors | ||
Treatment of stricture: | Treatment of stricture: | ||
Endoscopic pneumatic balloon dilatation | Endoscopic pneumatic balloon dilatation | ||
Management of GOO secondary to malignancy: | Management of GOO secondary to malignancy:\ | ||
Periampullary cancer: | Periampullary cancer: | ||
Clinical features: | Clinical features: | ||
Nausea | Nausea | ||
Vomiting | Vomiting | ||
In case of unresectable tumors: | In case of unresectable tumors: | ||
GOO is found in one fifth of these patients | GOO is found in one fifth of these patients | ||
Poor prognosis | |||
Gastrojejunostomy: surgery of choice for GOO secondary to malignancy | Poor prognosis | ||
Gastrojejunostomy: surgery of choice for GOO secondary to malignancy | |||
Laparoscopic gastrojejunostomy: | Laparoscopic gastrojejunostomy: | ||
Fast GI transit recovery time | Fast GI transit recovery time | ||
Fewer blood transfusions | Fewer blood transfusions | ||
Low mortality | Low mortality | ||
Brief hospital stay | Brief hospital stay | ||
Endoscopic surgery: | Endoscopic surgery: | ||
Magnetic gastroenteric anastomosis: preferred in cases of malignant obstruction | Magnetic gastroenteric anastomosis: preferred in cases of malignant obstruction | ||
Advantages: | Advantages: | ||
High success rate | High success rate | ||
Brief hospital stay | Brief hospital stay | ||
Low morbidity and mortality | Low morbidity and mortality | ||
Self-expandable metallic stents : in cases of GOO due to malignancy | Self-expandable metallic stents : in cases of GOO due to malignancy | ||
Complications of metallic stents are as follows: | Complications of metallic stents are as follows: | ||
Malposition | Malposition | ||
Misdeployment | Misdeployment | ||
Tumor ingrowth or overgrowth | Tumor ingrowth or overgrowth | ||
Migration | Migration | ||
Bleeding | Bleeding | ||
Perforation | Perforation | ||
| Line 559: | Line 543: | ||
Bleeding | Bleeding | ||
Perforation | Perforation | ||
Revision as of 19:00, 24 January 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
GASTRIC OUTLET OBSTRUCTION: Pyloric obstruction
Gastric outlet obstruction (GOO,) is the result of any pathology that provides mechanical obstruction to emptying of gastric contents. Two important causes of GOO include: Benign: 37 percent of cases, includes peptic disease Malignant: 53 percent of cases
Location of the stomach: Left upper quadrant of the abdomen Parts of the stomach: Cardia Body Antrum Pylorus
TREATMENT
All patients with suspected GOO require surgery.
Benign GOO due to PUD:
Medical therapy is given in case of: Acute inflammation Edema
SURGERY Surgery is required in more than three fourth of the cases Aim of surgery Relief of obstruction Correction of PUD symptoms Preparation for surgery Preoperative evaluation Correct fluid and electrolyte abnormalities Gastric decompression using NG tube Nutritional evaluation
Nutritional therapy: TPN
Enteral feedings via percutaneous jejunostomy
In case of scarring and fibrosis, surgery is the primary modality
Failure to respond to medical therapy
Absence of improvement after 72 hours
Types of procedures employed include: Vagotomy and antrectomy Gastrojejunostomy: Vagotomy and antrectomy with Billroth II reconstruction Balloon dilatation Side effect: Gastroparesis Recurrence
Pyloroplasty Robotic-assisted pyloroplasty Side effect: Gastric outlet scarring
Vagotomy and pyloroplasty Truncal vagotomy and gastrojejunostomy Laproscopic truncal vagotomy Laproscopic gastrojejunostomy Laparoscopic pyloromyotomy
Guidelines for surgery: Major resections of the tumor must be done in the absence of metastatic disease Patient should be able to tolerate surgery In case of metastatic disease, extent of surgery needs to be determined
Contraindications: Severe malnutrition Advanced cancer
Prior to surgery: Gastric decompression Hydration Treatment of electrolyte imbalances
Palliative therapy for cases of advanced cancer:
Endoscopic stent placement
Medical Therapy
Hydration
Correction of electrolyte imbalances
NaCl solution to correct hypochloremia
Replacement of potassium
Repletion of volume status
Placement of a nasogastric (NG) tube for stomach decompression
Jejunostomy tube may be placed during surgery
In case of PUD:
Histamine-2 (H2) blockers
Proton pump inhibitors
Treatment of stricture: Endoscopic pneumatic balloon dilatation
Management of GOO secondary to malignancy:
Periampullary cancer:
Clinical features: Nausea Vomiting
In case of unresectable tumors:
GOO is found in one fifth of these patients Poor prognosis Gastrojejunostomy: surgery of choice for GOO secondary to malignancy.
Laparoscopic gastrojejunostomy:
Fast GI transit recovery time Fewer blood transfusions Low mortality Brief hospital stay
Endoscopic surgery: Magnetic gastroenteric anastomosis: preferred in cases of malignant obstruction
Advantages: High success rate Brief hospital stay Low morbidity and mortality Self-expandable metallic stents : in cases of GOO due to malignancy Complications of metallic stents are as follows: Malposition Misdeployment Tumor ingrowth or overgrowth Migration Bleeding Perforation
Historical Perspective
Classification
Pathophysiology
Gastric Outlet Obstruction (GOO) may be caused by intrinsic or extrinsic pathologies that involve the antrum and the pylorus.
- Intrinsic obstruction:
- Infiltration, scar formation or inflammation of these structures leads to intrinsic obstruction, resulting in GOO.
- Extrinsic obstruction:
- Malignancy of any of these neighboring structures may lead to extrinsic obstruction of the gastric outlet:
Causes
Benign causes
- Acute- edema and inflammation
- Chronic- due to intrinsic obstruction as a result of fibrosis and scar formation
- PUD: 5% cases (most commonly affecting pylorus and initial part of the duodenum)
- Gastric polyps[5][6]
- Caustic ingestion[7]
- Duodenal stricture [8]
- Systemic amyloidosis of the gastrointestinal tract [9][10]
- Eosinophillic gastroenteritis [11][12][13][14][15]
- Obstruction by gallstones (Bouveret syndrome)
- Complication of acute pancreatitis: pancreatic pseudocyst formation[16][17]
- Chronic pancreatitis [18][19]
- Sarcoidosis of the GIT [20][21][22][23]
- Bezoars[24][25][26][27][28]
- Crohn's disease involving the duodenum [29][30][31][32]
- Gastro-duodenal tuberculosis[33][34][35][36][37]
- Pyloric stenosis:
- Most common cause in children
- More common in boys>girls
- Due to hypertrophy of pyloric circular smooth muscles
- Congenital duodenal webs[40]
- Annular pancreas[41]
Malignant causes
- Malignancies involving neighboring structures:[42][43][44][45][46][47]
- Pancreas: Pancreatic cancer
- Most common malignancy leading to extrinsic obstruction of the pylorus
- Occurence in one fifth of patients
- Stomach: Gastric cancer, Zollinger-Ellison Syndrome [48]
- Duodenum: Duodenal cancer, ampullary cancer
- Bile duct: Cholangiocarcinoma
- Secondary metastasis to the gastric outlet by other primaries
- Pancreas: Pancreatic cancer
Differentiating Gastric outlet obstruction from Other Diseases
Epidemiology and Demographics
- Incidence: less than 5% in patients with PUD.
- PUD is the most common benign cause of GOO.
- In the US, five percent PUD cases require an average of 2000 surgeries annually.
- Pancreatic cancer is the most common malignant cause of GOO.
- The incidence of GOO in cases with pancreatic cancer is approximately 20%.
Risk Factors
Screening
Natural History, Complications, and Prognosis
Natural History
Complications
Prognosis
Diagnosis
History and Symptoms
The following history is relevant in patients with GOO:[49][50]
- History of Peptic Ulcer Disease (PUD) or its complications
- Indigestion
- Anorexia
- Nausea, vomiting
- Epigastric pain
- History of abdominal pain and weight loss in cases of pancreatic cancer
Clinical presentation:
- Nausea
- Vomiting: characteristic feature
- Intermittent
- Occurs one hour after ingestion
- Non bilious
- Contains undigested particles of food
- Patient has intolerance to solids, followed by liquids
- Dehydration
- Electrolyte abnormalities
- Weight loss
- Malnutrition: more pronounced in patients with malignancy
- Abdominal distension
- Features of incomplete obstruction
- Gastric retention: presenting as early satiety
- Bloating
- Fullness of epigastrium
- Aspiration pneumonia: due to dilatation of stomach, loss of contractility and accumulation of undigested food contents
Physical Examination
In the late stages of GOO, patients may develop signs of malnutrition and incomplete obstruction.
- Weight loss
- Signs of chronic dehydration
- Malnutrition: more pronounced in patients with malignancy
- Abdominal distension
- Features of incomplete obstruction
- Aspiration pneumonia
- Abdominal examination:
- Abdominal mass may be present
- Location: Epigastrium, Left upper quadrant of the abdomen
- Palpation: Fullness of epigastrium
- Percussion: Tympanitic mass
Laboratory Findings
- Characteristic features due to vomiting:[53]
- Complete Blood Count (CBC): may show anemia
- Electrolyte panel
- Liver function tests: in case of malignancy
- Test for H pylori for diagnosis of PUD
Imaging Findings
Imaging studies such as plain radiographs, contrast upper gastrointestinal (GI) studies and Computed Tomography (CT) with oral contrast may be used for evaluating patients with symptoms of GOO.
Plain radiographs
- Obstruction series includes:
- This helps in the determination of the presence of gastric dilatation.
Contrast upper gastrointestinal (GI) studies (Gastrografin or barium)
- Barium upper GI studies:
- Helps in the determination of site of obstruction
- Helps in the visualization of the gastric silhouette:
- Helps note the following:
- Nuclear gastric emptying study:
- Radionuclide is given orally and its passage is measured over a certain duration.
Computed tomography (CT) with oral contrast
- CT with oral contrast may also be of use in suspected cases with equivocal findings on X Ray and Barium Upper GI studies. CT-guided biopsy may be especially useful in cases of pancreatic cancer.
Other Diagnostic Studies
Endoscopy
- Upper endoscopy may help with:[54][55]
- Visualization of the gastric outlet
- Biopsy sampling in case of intraluminal pathology
- Endoscopic biopsy helps rule out the presence of malignancy in patients with symptoms of Peptic Ulcer Disease (PUD)
Sodium chloride load test
- Procedure: Patient is infused with 750 mL of sodium chloride solution into the stomach via a nasogastric tube (NGT).[56][56]
- In case > 400 mL is left in the stomach after half an hour, the diagnosis of GOO may be made.
Needle-guided biopsy
- Helps in the evaluation of patients for metastasis
Treatment
Medical Therapy
Benign Gastric Outlet Obstruction due to Peptic Ulcer Disease (PUD):
Medical therapy is given in patients in case of:
Acute inflammation
Edema
Prior to surgery:
Gastric decompression
Hydration
Treatment of electrolyte imbalances
Palliative therapy for cases of advanced cancer:
Endoscopic stent placement
Medical Therapy
Hydration
Correction of electrolyte imbalances
NaCl solution to correct hypochloremia
Replacement of potassium
Repletion of volume status
Placement of a nasogastric (NG) tube for stomach decompression
Jejunostomy tube may be placed during surgery
In case of PUD:
Histamine-2 (H2) blockers
Proton pump inhibitors
Treatment of stricture:
Endoscopic pneumatic balloon dilatation
Management of GOO secondary to malignancy:\
Periampullary cancer:
Clinical features:
Nausea
Vomiting
In case of unresectable tumors:
GOO is found in one fifth of these patients
Poor prognosis
Gastrojejunostomy: surgery of choice for GOO secondary to malignancy
Laparoscopic gastrojejunostomy:
Fast GI transit recovery time
Fewer blood transfusions
Low mortality
Brief hospital stay
Endoscopic surgery:
Magnetic gastroenteric anastomosis: preferred in cases of malignant obstruction
Advantages:
High success rate
Brief hospital stay
Low morbidity and mortality
Self-expandable metallic stents : in cases of GOO due to malignancy
Complications of metallic stents are as follows:
Malposition
Misdeployment
Tumor ingrowth or overgrowth
Migration
Bleeding
Perforation
Surgery
TREATMENT
All patients with suspected GOO require surgery.
Benign GOO due to PUD:
Medical therapy is given in case of: Acute inflammation Edema
SURGERY Surgery is required in more than three fourth of the cases Aim of surgery Relief of obstruction Correction of PUD symptoms Preparation for surgery Preoperative evaluation Correct fluid and electrolyte abnormalities Gastric decompression using NG tube Nutritional evaluation
Nutritional therapy: TPN
Enteral feedings via percutaneous jejunostomy
In case of scarring and fibrosis, surgery is the primary modality
Failure to respond to medical therapy
Absence of improvement after 72 hours
Types of procedures employed include: Vagotomy and antrectomy Gastrojejunostomy: Vagotomy and antrectomy with Billroth II reconstruction Balloon dilatation Side effect: Gastroparesis Recurrence
Pyloroplasty Robotic-assisted pyloroplasty Side effect: Gastric outlet scarring
Vagotomy and pyloroplasty Truncal vagotomy and gastrojejunostomy Laproscopic truncal vagotomy Laproscopic gastrojejunostomy Laparoscopic pyloromyotomy
Guidelines for surgery: Major resections of the tumor must be done in the absence of metastatic disease Patient should be able to tolerate surgery In case of metastatic disease, extent of surgery needs to be determined
Contraindications: Severe malnutrition Advanced cancer
Prior to surgery: Gastric decompression Hydration Treatment of electrolyte imbalances
Palliative therapy for cases of advanced cancer:
Endoscopic stent placement
Medical Therapy
Hydration
Correction of electrolyte imbalances
NaCl solution to correct hypochloremia
Replacement of potassium
Repletion of volume status
Placement of a nasogastric (NG) tube for stomach decompression
Jejunostomy tube may be placed during surgery
In case of PUD:
Histamine-2 (H2) blockers
Proton pump inhibitors
Treatment of stricture: Endoscopic pneumatic balloon dilatation
Management of GOO secondary to malignancy:
Periampullary cancer:
Clinical features: Nausea Vomiting
In case of unresectable tumors:
GOO is found in one fifth of these patients Poor prognosis Gastrojejunostomy: surgery of choice for GOO secondary to malignancy.
Laparoscopic gastrojejunostomy:
Fast GI transit recovery time Fewer blood transfusions Low mortality Brief hospital stay
Endoscopic surgery: Magnetic gastroenteric anastomosis: preferred in cases of malignant obstruction
Advantages: High success rate Brief hospital stay Low morbidity and mortality Self-expandable metallic stents : in cases of GOO due to malignancy Complications of metallic stents are as follows: Malposition Misdeployment Tumor ingrowth or overgrowth Migration Bleeding Perforation
Prevention
References
- ↑ Bradley EL, Clements JL (1981). "Idiopathic duodenal obstruction: an unappreciated complication of pancreatitis". Ann. Surg. 193 (5): 638–48. PMC 1345138. PMID 7235767.
- ↑ Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK (1992). "Ingestion of strong corrosive alkalis: spectrum of injury to upper gastrointestinal tract and natural history". Am. J. Gastroenterol. 87 (3): 337–41. PMID 1539568.
- ↑ Poley JW, Steyerberg EW, Kuipers EJ, Dees J, Hartmans R, Tilanus HW, Siersema PD (2004). "Ingestion of acid and alkaline agents: outcome and prognostic value of early upper endoscopy". Gastrointest. Endosc. 60 (3): 372–7. PMID 15332026.
- ↑ Ciftci AO, Senocak ME, Büyükpamukçu N, Hiçsönmez A (1999). "Gastric outlet obstruction due to corrosive ingestion: incidence and outcome". Pediatr. Surg. Int. 15 (2): 88–91. doi:10.1007/s003830050523. PMID 10079337.
- ↑ 5.0 5.1 Miner PB, Harri JE, McPhee MS (1982). "Intermittent gastric outlet obstruction from a pedunculated gastric polyp". Gastrointest. Endosc. 28 (3): 219–20. PMID 7129059.
- ↑ Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Tozun N (2003). "Antral hyperplastic polyp causing intermittent gastric outlet obstruction: case report". BMC Gastroenterol. 3: 16. doi:10.1186/1471-230X-3-16. PMC 166166. PMID 12831404.
- ↑ Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK (1989). "Ingestion of corrosive acids. Spectrum of injury to upper gastrointestinal tract and natural history". Gastroenterology. 97 (3): 702–7. PMID 2753330.
- ↑ Taylor SM, Adams DB, Anderson MC (1991). "Duodenal stricture: a complication of chronic fibrocalcific pancreatitis". South. Med. J. 84 (3): 338–41. PMID 2000520.
- ↑ Menke DM, Kyle RA, Fleming CR, Wolfe JT, Kurtin PJ, Oldenburg WA (1993). "Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis". Mayo Clin. Proc. 68 (8): 763–7. PMID 8331978.
- ↑ Friedman S, Janowitz HD (1998). "Systemic amyloidosis and the gastrointestinal tract". Gastroenterol. Clin. North Am. 27 (3): 595–614, vi. PMID 9891699.
- ↑ Khan S, Orenstein SR (2000). "Eosinophilic gastroenteritis masquerading as pyloric stenosis". Clin Pediatr (Phila). 39 (1): 55–7. doi:10.1177/000992280003900109. PMID 10660821.
- ↑ Chaudhary R, Shrivastava RK, Mukhopadhyay HG, Diwan RN, Das AK (2001). "Eosinophilic gastritis--an unusual cause of gastric outlet obstruction". Indian J Gastroenterol. 20 (3): 110. PMID 11400803.
- ↑ Tursi A, Rella G, Inchingolo CD, Maiorano M (2007). "Gastric outlet obstruction due to gastroduodenal eosinophilic gastroenteritis". Endoscopy. 39 Suppl 1: E184. doi:10.1055/s-2006-945125. PMID 17614041.
- ↑ Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE (2003). "Eosinophilic gastroenteritis: clinical experience with 15 patients". World J. Gastroenterol. 9 (12): 2813–6. PMC 4612059. PMID 14669340.
- ↑ Lee CM, Changchien CS, Chen PC, Lin DY, Sheen IS, Wang CS, Tai DI, Sheen-Chen SM, Chen WJ, Wu CS (1993). "Eosinophilic gastroenteritis: 10 years experience". Am. J. Gastroenterol. 88 (1): 70–4. PMID 8420276.
- ↑ Aranha GV, Prinz RA, Greenlee HB, Freeark RJ (1984). "Gastric outlet and duodenal obstruction from inflammatory pancreatic disease". Arch Surg. 119 (7): 833–5. PMID 6732492.
- ↑ Agrawal NM, Gyr N, McDowell W, Font RG (1974). "Intestinal obstruction due to acute pancreatitis. Case report and review of literature". Am J Dig Dis. 19 (2): 179–85. PMID 4811173.
- ↑ Bradley EL (1989). "Complications of chronic pancreatitis". Surg. Clin. North Am. 69 (3): 481–97. PMID 2658160.
- ↑ Levenick JM, Gordon SR, Sutton JE, Suriawinata A, Gardner TB (2009). "A comprehensive, case-based review of groove pancreatitis". Pancreas. 38 (6): e169–75. doi:10.1097/MPA.0b013e3181ac73f1. PMID 19629001.
- ↑ Stampfl DA, Grimm IS, Barbot DJ, Rosato FE, Gordon SJ (1990). "Sarcoidosis causing duodenal obstruction. Case report and review of gastrointestinal manifestations". Dig. Dis. Sci. 35 (4): 526–32. PMID 2180656.
- ↑ Johnson FE, Humbert JR, Kuzela DC, Todd JK, Lilly JR (1975). "Gastric outlet obstruction due to X-linked chronic granulomatous disease". Surgery. 78 (2): 217–23. PMID 807981.
- ↑ Mulholland MW, Delaney JP, Simmons RL (1983). "Gastrointestinal complications of chronic granulomatous disease: surgical implications". Surgery. 94 (4): 569–75. PMID 6623357.
- ↑ Huang A, Abbasakoor F, Vaizey CJ (2006). "Gastrointestinal manifestations of chronic granulomatous disease". Colorectal Dis. 8 (8): 637–44. doi:10.1111/j.1463-1318.2006.01030.x. PMID 16970572.
- ↑ Bakken DA, Abramo TJ (1997). "Gastric lactobezoar: a rare cause of gastric outlet obstruction". Pediatr Emerg Care. 13 (4): 264–7. PMID 9291515.
- ↑ De Backer A, Van Nooten V, Vandenplas Y (1999). "Huge gastric trichobezoar in a 10-year-old girl: case report with emphasis on endoscopy in diagnosis and therapy". J. Pediatr. Gastroenterol. Nutr. 28 (5): 513–5. PMID 10328129.
- ↑ Phillips MR, Zaheer S, Drugas GT (1998). "Gastric trichobezoar: case report and literature review". Mayo Clin. Proc. 73 (7): 653–6. doi:10.1016/S0025-6196(11)64889-1. PMID 9663194.
- ↑ White NB, Gibbs KE, Goodwin A, Teixeira J (2003). "Gastric bezoar complicating laparoscopic adjustable gastric banding, and review of literature". Obes Surg. 13 (6): 948–50. doi:10.1381/096089203322618849. PMID 14738689.
- ↑ Zapata R, Castillo F, Córdova A (2006). "[Gastric food bezoar as a complication of bariatric surgery. Case report and review of the literature]". Gastroenterol Hepatol (in Spanish; Castilian). 29 (2): 77–80. PMID 16448609.
- ↑ Nugent FW, Roy MA (1989). "Duodenal Crohn's disease: an analysis of 89 cases". Am. J. Gastroenterol. 84 (3): 249–54. PMID 2919581.
- ↑ Kefalas CH (2003). "Gastroduodenal Crohn's disease". Proc (Bayl Univ Med Cent). 16 (2): 147–51. PMC 1201000. PMID 16278730.
- ↑ Matsui T, Hatakeyama S, Ikeda K, Yao T, Takenaka K, Sakurai T (1997). "Long-term outcome of endoscopic balloon dilation in obstructive gastroduodenal Crohn's disease". Endoscopy. 29 (7): 640–5. doi:10.1055/s-2007-1004271. PMID 9360875.
- ↑ Fitzgibbons TJ, Green G, Silberman H, Eliasoph J, Halls JM, Yellin AE (1980). "Management of Crohn's disease involving the duodenum, including duodenal cutaneous fistula". Arch Surg. 115 (9): 1022–8. PMID 6106466.
- ↑ Amarapurkar DN, Patel ND, Amarapurkar AD (2003). "Primary gastric tuberculosis--report of 5 cases". BMC Gastroenterol. 3: 6. PMC 155648. PMID 12703983.
- ↑ Rao YG, Pande GK, Sahni P, Chattopadhyay TK (2004). "Gastroduodenal tuberculosis management guidelines, based on a large experience and a review of the literature". Can J Surg. 47 (5): 364–8. PMC 3211943. PMID 15540690.
- ↑ Padussis J, Loffredo B, McAneny D (2005). "Minimally invasive management of obstructive gastroduodenal tuberculosis". Am Surg. 71 (8): 698–700. PMID 16217956.
- ↑ Di Placido R, Pietroletti R, Leardi S, Simi M (1996). "Primary gastroduodenal tuberculous infection presenting as pyloric outlet obstruction". Am. J. Gastroenterol. 91 (4): 807–8. PMID 8677960.
- ↑ Subei I, Attar B, Schmitt G, Levendoglu H (1987). "Primary gastric tuberculosis: a case report and literature review". Am. J. Gastroenterol. 82 (8): 769–72. PMID 3605037.
- ↑ Kreel L, Ellis H (1965). "Pyloric stenosis in adults: A clinical and radiological study of 100 consecutive patients". Gut. 6 (3): 253–61. PMC 1552275. PMID 18668780.
- ↑ Gheorghe L, Băncilă I, Gheorghe C, Herlea V, Vasilescu C, Aposteanu G (2002). "Antro-duodenal tuberculosis causing gastric outlet obstruction--a rare presentation of a protean disease". Rom J Gastroenterol. 11 (2): 149–52. PMID 12145672.
- ↑ Adebamowo CA, Oduntan O (1999). "Duodenal web causing gastric outlet obstruction in an adult". West Afr J Med. 18 (1): 73–4. PMID 10876738.
- ↑ 41.0 41.1 Urayama S, Kozarek R, Ball T, Brandabur J, Traverso L, Ryan J, Wechter D (1995). "Presentation and treatment of annular pancreas in an adult population". Am. J. Gastroenterol. 90 (6): 995–9. PMID 7771437.
- ↑ Johnson CD (1995). "Gastric outlet obstruction malignant until proved otherwise". Am. J. Gastroenterol. 90 (10): 1740. PMID 7572886.
- ↑ 43.0 43.1 Shone DN, Nikoomanesh P, Smith-Meek MM, Bender JS (1995). "Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers". Am. J. Gastroenterol. 90 (10): 1769–70. PMID 7572891.
- ↑ 44.0 44.1 Johnson CD, Ellis H (1990). "Gastric outlet obstruction now predicts malignancy". Br J Surg. 77 (9): 1023–4. PMID 2207566.
- ↑ Tendler DA (2002). "Malignant gastric outlet obstruction: bridging another divide". Am. J. Gastroenterol. 97 (1): 4–6. doi:10.1111/j.1572-0241.2002.05391.x. PMID 11808968.
- ↑ Jeong HY, Yang HW, Seo SW, Seong JK, Na BK, Lee BS, Song GS, Park HS, Lee HY (2002). "Adenocarcinoma arising from an ectopic pancreas in the stomach". Endoscopy. 34 (12): 1014–7. doi:10.1055/s-2002-35836. PMID 12471549.
- ↑ Emerson L, Layfield LJ, Rohr LR, Dayton MT (2004). "Adenocarcinoma arising in association with gastric heterotopic pancreas: A case report and review of the literature". J Surg Oncol. 87 (1): 53–7. doi:10.1002/jso.20087. PMID 15221920.
- ↑ Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT (2000). "Zollinger-Ellison syndrome. Clinical presentation in 261 patients". Medicine (Baltimore). 79 (6): 379–411. PMID 11144036.
- ↑ Green ST, Drury JK, McCallion J, Erwin L (1987). "Carcinoid tumour presenting as recurrent gastric outlet obstruction: a case of long-term survival". Scott Med J. 32 (2): 54–5. doi:10.1177/003693308703200212. PMID 3602991.
- ↑ Chowdhury A, Dhali GK, Banerjee PK (1996). "Etiology of gastric outlet obstruction". Am. J. Gastroenterol. 91 (8): 1679. PMID 8759707.
- ↑ Cappell MS, Davis M (2006). "Characterization of Bouveret's syndrome: a comprehensive review of 128 cases". Am. J. Gastroenterol. 101 (9): 2139–46. doi:10.1111/j.1572-0241.2006.00645.x. PMID 16817848.
- ↑ Dubois A, Price SF, Castell DO (1978). "Gastric retention in peptic ulcer disease. A reappraisal". Am J Dig Dis. 23 (11): 993–7. PMID 717362.
- ↑ Hangen D, Maltz GS, Anderson JE, Knauer CM (1989). "Marked hypergastrinemia in gastric outlet obstruction". J. Clin. Gastroenterol. 11 (4): 442–4. PMID 2760432.
- ↑ Lau JY, Chung SC, Sung JJ, Chan AC, Ng EK, Suen RC, Li AK (1996). "Through-the-scope balloon dilation for pyloric stenosis: long-term results". Gastrointest. Endosc. 43 (2 Pt 1): 98–101. PMID 8635729.
- ↑ Awan A, Johnston DE, Jamal MM (1998). "Gastric outlet obstruction with benign endoscopic biopsy should be further explored for malignancy". Gastrointest. Endosc. 48 (5): 497–500. PMID 9831838.
- ↑ 56.0 56.1 Goldstein H, Boyle JD (1965). "The saline load test--a bedside evaluation of gastric retention". Gastroenterology. 49 (4): 375–80. PMID 5831782.